As of 2024-12-11, the Relative Valuation of SkinBioTherapeutics PLC (SBTX.L) is (17.08) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 16.50 GBP, the upside of SkinBioTherapeutics PLC based on Relative Valuation is -203.5%.
The range of the Relative Valuation is (18.47) - (17.02) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 13.8x | 11.0x |
| Forward P/E multiples | 15.0x - 19.4x | 16.7x |
| Fair Price | (18.47) - (17.02) | (17.08) |
| Upside | -212.0% - -203.1% | -203.5% |
| Date | P/E |
| 2024-11-29 | -12.97 |
| 2024-11-28 | -12.87 |
| 2024-11-27 | -12.87 |
| 2024-11-26 | -12.87 |
| 2024-11-25 | -12.87 |
| 2024-11-22 | -12.97 |
| 2024-11-21 | -12.87 |
| 2024-11-20 | -13.18 |
| 2024-11-19 | -12.67 |
| 2024-11-18 | -11.56 |
| 2024-11-15 | -11.05 |
| 2024-11-14 | -11.15 |
| 2024-11-13 | -11.05 |
| 2024-11-12 | -11.35 |
| 2024-11-11 | -11.86 |
| 2024-11-08 | -11.86 |
| 2024-11-07 | -11.56 |
| 2024-11-06 | -11.96 |
| 2024-11-05 | -12.41 |
| 2024-11-04 | -12.77 |
| 2024-11-01 | -13.48 |
| 2024-10-31 | -13.38 |
| 2024-10-30 | -13.46 |
| 2024-10-29 | -14.39 |
| 2024-10-28 | -15.00 |
| 2024-10-25 | -13.08 |
| 2024-10-24 | -11.56 |
| 2024-10-23 | -10.74 |
| 2024-10-22 | -11.05 |
| 2024-10-21 | -11.96 |
| 2024-10-18 | -12.16 |
| 2024-10-17 | -11.96 |
| 2024-10-16 | -11.96 |
| 2024-10-15 | -11.43 |
| 2024-10-14 | -10.99 |
| 2024-10-11 | -10.22 |
| 2024-10-10 | -9.12 |
| 2024-10-09 | -9.12 |
| 2024-10-08 | -9.12 |
| 2024-10-07 | -9.12 |
| 2024-10-04 | -8.62 |
| 2024-10-03 | -8.41 |
| 2024-10-02 | -8.72 |
| 2024-10-01 | -8.72 |
| 2024-09-30 | -8.82 |
| 2024-09-27 | -8.62 |
| 2024-09-26 | -8.62 |
| 2024-09-25 | -8.62 |
| 2024-09-24 | -8.60 |
| 2024-09-23 | -8.72 |